Biostable Aptamer Rings Conjugated for Targeting Two Biomarkers on Circulating Tumor Cells in Vivo with Great Precision
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Cancer metastatic spread is life-threatening and caused by circulating tumor cells (CTCs) that are very difficult to precisely capture in vivo. Here we show that two aptamer rings targeting different CTC biomarker epitopes conjugated on dendrimers capture CTCs with enhanced precision even in the presence of 10 8 interfering cells, or blood cells, and in mice or patient samples when compared with their single aptamer counterparts. The aptamer-conjugate inhibited in vivo metastasis and demonstrated enhanced biostability by resisting biodegradation caused by the endogenous nucleases. The capture arms of the aptamer conjugates could simultaneously and specifically seize two biomarkers (EpCAM and Her2). The double seizure resulted in significant cell-cycle arrest, apoptosis, and growth inhibition of the captured CTCs. The aptamer-conjugate highly penetrated and accumulated in mouse tumors. This study provides the first conceptual evidence that two aptamer rings, inexpensive but bioequivalent to their antibodies, can be biocompatibly conjugated to specifically capture and down-regulate CTCs in vivo with the enhanced biostability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This aptamer-conjugate can work properly when 108 interfering cells or blood cells that do not express EpCAM or Her2 are present, as well as in complex biological samples of patients and mice with greatly enhanced bio-stability and high capturing precision.”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [154]
In the citing paper
“In this formulation, capture arms could distinctly bind two biomarkers at the same time (EpCAM and Her2). This, induced apoptosis as a result of the arrestment of cell cycle and the inhibition of tumor progression in captured CTCs (Fig. 3) [154].”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [154]
In the citing paper
“The aptamer-conjugate impeded metastasis and displayed enhanced bio-stability against endogenous nucleases in vivo.”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [154]
In the citing paper
“Dong et al. reported on the design, synthesis, and description of the new dual double-stranded (ds) aptamer ring conjugate (cCAP1-G4.5-cCAP2) capable of simultaneously targeting EpCAM and Her2 epitopes on CTCs.”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [154]
Citations
Cites
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., Isakoff, S. J., Ciciliano, J. C., Wells, M. N., Shah, A. M., et al. (2013) · Science · doi:10.1126/science.1228522 · Cited by 2,476
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Gao, D., Vela, I., Sboner, A., Iaquinta, P. J., Karthaus, W. R., Gopalan, A., Dowling, C., Wanjala, J. N., Undvall, E. A., Arora, V. K., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.016 · Cited by 1,559
Aptamers evolved from live cells as effective molecular probes for cancer study
Shangguan, D., Li, Y., Tang, Z., Cao, Z. C., Chen, H. W., Mallikaratchy, P., Sefah, K., Yang, C. J., & Tan, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602615103 · Cited by 1,516
Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
Yu, M., Bardia, A., Aceto, N., Bersani, F., Madden, M. W., Donaldson, M. C., Desai, R., Zhu, H., Comaills, V., Zheng, Z., et al. (2014) · Science · doi:10.1126/science.1253533 · Cited by 913
DNA nanotechnology from the test tube to the cell
Chen, Y.-J., Groves, B., Muscat, R. A., & Seelig, G. (2015) · Nature Nanotechnology · doi:10.1038/nnano.2015.195 · Cited by 594
Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy
Sun, H., Zhu, X., Lu, P. Y., Rosato, R. R., Tan, W., & Zu, Y. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.32 · Cited by 541
Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets
Yoon, H. J., Kim, T. H., Zhang, Z., Azizi, E., Pham, T. M., Paoletti, C., Lin, J., Ramnath, N., Wicha, M. S., Hayes, D. F., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.194 · Cited by 534
Ferreira, C. S. M., Matthews, C. S., & Missailidis, S. (2006) · Tumor Biology · doi:10.1159/000096085 · Cited by 407
Establishment and Characterization of a Cell Line from Human Circulating Colon Cancer Cells
Cayrefourcq, L., Mazard, T., Joosse, S., Solassol, J., Ramos, J., Assenat, E., Schumacher, U., Costes, V., Maudelonde, T., Pantel, K., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2613 · Cited by 372
Specific Capture and Release of Circulating Tumor Cells Using Aptamer‐Modified Nanosubstrates
Shen, Q., Xu, L., Zhao, L., Wu, D., Fan, Y., Zhou, Y., OuYang, W., Xu, X., Zhang, Z., Song, M., et al. (2013) · Advanced Materials · doi:10.1002/adma.201300082 · Cited by 300
Cited by
Tumor microenvironment complexity and therapeutic implications at a glance
Baghban, R., Roshangar, L., Jahanban-Esfahlan, R., Seidi, K., Ebrahimi-Kalan, A., Jaymand, M., Kolahian, S., Javaheri, T., & Zare, P. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0530-4 · Cited by 1,784
“Adapted with permission from [154] .”
BackgroundAptamer-Based Detection of Circulating Targets for Precision Medicine
Wu, L., Wang, Y., Xu, X., Liu, Y., Lin, B., Zhang, M., Zhang, J., Wan, S., Yang, C., & Tan, W. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01140 · Cited by 705
Xue, C., Zhang, S., Yu, X., Hu, S., Lu, Y., & Wu, Z. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202004805 · Cited by 102
Self-citationXie, X., Nie, H., Zhou, Y., Lian, S., Mei, H., Lu, Y., Dong, H., Li, F., Li, T., Li, B., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13316-w · Cited by 102
Self-citationIn Vitro Selection of Circular DNA Aptamers for Biosensing Applications
Liu, M., Yin, Q., Chang, Y., Zhang, Q., Brennan, J. D., & Li, Y. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201901192 · Cited by 93
Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer
Sheikh, A., Md, S., & Kesharwani, P. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112530 · Cited by 89
Bacterial cellulose based composites enhanced transdermal drug targeting for breast cancer treatment
Zhang, L., Du, S., Wang, X., Jiao, Y., Yin, L., Zhang, Y., & Guan, Y. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.03.216 · Cited by 88
Construction and bioapplications of aptamer-based dual recognition strategy
Wang, Y., Liu, X., Wu, L., Ding, L., Effah, C. Y., Wu, Y., Xiong, Y., & He, L. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113661 · Cited by 79
Circular Nucleic Acids: Discovery, Functions and Applications
Li, J., Mohammed‐Elsabagh, M., Paczkowski, F., & Li, Y. (2020) · ChemBioChem · doi:10.1002/cbic.202000003 · Cited by 74
An update on dual targeting strategy for cancer treatment
Taghipour, Y. D., Zarebkohan, A., Salehi, R., Rahimi, F., Torchilin, V. P., Hamblin, M. R., & Seifalian, A. M. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.06.044 · Cited by 72
Ge, P., Niu, B., Wu, Y., Xu, W., Li, M., Sun, H., Zhou, H., Zhang, X.-K., & Xie, J. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.123228 · Cited by 64
Self-citationEvolution of a highly functional circular DNA aptamer in serum
Mao, Y., Gu, J., Chang, D., Wang, L., Yao, L., Ma, Q., Luo, Z., Qu, H., Li, Y., & Zheng, L. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa800 · Cited by 56
DNA nanotechnology in tumor liquid biopsy: Enrichment and determination of circulating biomarkers
Zhu, Y., Li, W., Lan, F., Chen, S., Chen, X., Zhang, X., Yan, X., & Zhang, Y. (2023) · Interdisciplinary medicine · doi:10.1002/inmd.20230043 · Cited by 52
Yang, L., Sun, H., Jiang, W., Xu, T., Song, B., Peng, R., Han, L., & Jia, L. (2018) · Chemistry of Materials · doi:10.1021/acs.chemmater.8b01646 · Cited by 42
Self-citationEmerging nanomedicine-based strategies for preventing metastasis of pancreatic cancer
Li, Y., Wu, J., Wang, J., & Xiang, D. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.041 · Cited by 42
Self-citationWang, J., Dong, H., Zhou, Y., Han, L., Zhang, T., Lin, M., Wang, C., Xu, H. Y., Wu, Z., & Jia, L. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.09.025 · Cited by 38
Self-citationSiemer, S., Gül, D., Khamis, A., Lü, Q., Scherberich, A., Filippi, M., Krafft, M. P., Hagemann, J., Weiß, C., Ding, G., et al. (2020) · Nanomaterials · doi:10.3390/nano10020383 · Cited by 39
Sun, S., Yang, S., Hu, X., Zheng, C., Song, H., Wang, L., Shen, Z., & Wu, Z. (2020) · ACS Sensors · doi:10.1021/acssensors.0c01082 · Cited by 37
Self-citationDong, H., Han, L., Wang, J., Xie, J., Gao, Y., Xie, F., & Jia, L. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.004 · Cited by 32
Self-citationXie, R., Lian, S., Peng, H., Ouyang, C., Li, S., Lu, Y., Cao, X., Zhang, C., Xu, J., & Jia, L. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00259 · Cited by 34
Self-citationGribko, A., Künzel, J., Gül, D., Lü, Q., Nagel, S. M., Knauer, S. K., Stauber, R. H., & Ding, G. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s198319 · Cited by 34
Programming CircLigase Catalysis for DNA Rings and Topologies
Li, Q., Zhang, S., Li, W., Ge, Z., Fan, C., & Gu, H. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c04668 · Cited by 30
Niu, B., Wu, Y., Zhou, M., Lin, R., Ge, P., Chen, X., Zhou, H., Zhang, X.-K., & Xie, J. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216461 · Cited by 25
Self-citationRecent Advances in Computer-aided Virtual Screening and Docking Optimization for Aptamer
Liu, Y., Yang, J., Chen, M., Lü, X., Wei, Z. X., Tang, C., & Yu, P. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230623145802 · Cited by 28
Xue, C., Zhang, S., Yu, X., Hu, S., Lu, Y., & Wu, Z. (2020) · Angewandte Chemie · doi:10.1002/ange.202004805 · Cited by 22
Self-citationLe, J., Xu, J., Zheng, J., Li, B., Zheng, T., Lu, Y., Shen, W., Kudryavtseva, A. V., Katanaev, V. L., Shao, J., et al. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.124170 · Cited by 17
Self-citationAptamers for the Delivery of Plant-Based Compounds: A Review
Gamboa, J., Lourenço, P., Cruz, C., & Gallardo, E. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040541 · Cited by 16
In Vitro Selection of Circular DNA Aptamers for Biosensing Applications
Liu, M., Yin, Q., Chang, Y., Zhang, Q., Brennan, J. D., & Li, Y. (2019) · Angewandte Chemie · doi:10.1002/ange.201901192 · Cited by 11
Li, Y., Zhang, T., Huang, J., Dong, H., Xie, J., & Jia, L. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s287720 · Cited by 8
Self-citationLong cruising aptamer-albumin nanobots intelligently capture and restrain circulating tumor cells
Wang, J., Xu, H. Y., Li, S., Lin, M., Lu, Y., Liu, K., Katanaev, V. L., Denisov, E. V., & Jia, L. (2023) · Nano Today · doi:10.1016/j.nantod.2023.102002 · Cited by 5
Self-citationWu, G., Zhang, Y., Fu, T., He, J., Liu, X., & Tan, W. (2026) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2026.119135 · Cited by 1
Wu, J., Liu, R., Chen, Y.-R., Zheng, X., & Wu, Z. (2021) · Biomaterials Science · doi:10.1039/d0bm00085j · Cited by 1
Self-citationNanobiotechnology for Therapeutic Targeting of Circulating Tumor Cells in the Blood
Biswas, N., Sahu, B. P., & Das, M. K. (2020) · Springer eBooks · doi:10.1007/978-981-15-6255-6_2 · Cited by 1
Toxicology and Biocompatibility of Nanomaterials
Weiß, C., & Diabaté, S. (2021) · MDPI eBooks · doi:10.3390/books978-3-0365-2738-3
The Tumor Microenvironment: Immunological Interactions and Therapeutic Targeting
Zgura, A. F., Anghel, R. M., & Chipuc, S. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1011106
Functional exploration of the Plasmodium tRNA import machinery
Pitolli, M. (2023) · theses.fr (ABES) · doi:10.70675/088f0755z4f29z434czb21fze696e294b023
Metadata
- Authors
- Dong, H., Han, L., Wu, Z.-S., Zhang, T., Xie, J., Ma, J., Wang, J., Li, T., Gao, Y., Shao, J., Sinko, P. J., & Jia, L.
- Affiliations
- Fujian Medical University (CN)
- Fuzhou University (CN)
- Xiamen University (CN)
- Rutgers, The State University of New Jersey (US)
- Corresponding author
- Jia, Lee
- ORCID
- Venue
- Chemistry of Materials
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-12-07
- Volume
- 29
- Issue
- 24
- Pages
- 10312-10325
- ISSN
- 0897-4756 (ISSN-L)
- 1520-5002
- OpenAlex
- W2773811223
- Cited by
- 36
- References
- 38
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 5 · 2022: 1 · 2021: 6 · 2020: 11 · 2019: 7 · 2018: 3
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemistry of Materials (publishedVersion)
- Funders
- Ministry of Science and Technology of the People's Republic of China (2015CB931804)
- Natural Science Foundation of Fujian Province (2016J06020, 2017J05137)
- National Natural Science Foundation of China (81273548, 81571802, 81702988, 81773063, U1505225)
- Principal Fund, Xiamen University (20720160061)
- Fujian Provincial Development And Reform Commission (829054)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- circulating tumor cells, dendrimers, EpCAM, HER2, metastasis suppression, biostability, tumor cell capture, cell cycle arrest, apoptosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.